- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Cyteir slides in $80m
Returning backer Novo was among the investors in a series C round for the synthetic cancer treatment developer that was led by RA Capital Management.
Feb 12, 2021Enevate recharges with $81m
The vehicle charging technology developer, which counts Sumitomo, LG Chem, Samsung, Bangchak and Lenovo as investors, has now raised $191m in total.
Feb 12, 2021Daily deal net: February 12, 2021
Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.
Feb 12, 2021Labster gets $60m result in series C round
Swisscom Ventures participated in a round that lifted the total raised by the laboratory simulation software provider to $104m.
Feb 12, 2021Monad hones $31m series A
The life sciences research technology developer has received funding in a series A round co-led by corporate investor ABclonal.
Feb 12, 2021Vivun gives details of $35m series B
Salesforce Ventures and Atlassian Ventures helped the pre-sales software developer boost its funding to $56m altogether.
Feb 12, 2021Jackpocket scores $50m in series C round
The lottery ticket purchasing app provider said it saw record new user growth last month, as it secured funding from investors including Tegna and Circle K.
Feb 12, 2021Isotropic measures out $40m
Boeing HorizonX and SES Engineering both strapped themselves into the satellite technology developer's latest round, bringing its overall funding to about $60m.
Feb 12, 2021Exits: February 8-12, 2021
The past week's M&A exits included Genetirate, DataFleets and SightGlass Vision.
Feb 12, 2021Evolve BioSystems revolves to series D
UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.
Feb 12, 2021Cyteir cites $80m series C investors
Osage University Partners has contributed to an oversubscribed series C round for Cyteir, which was led by RA Capital.
Feb 12, 2021Insightin inspires with $12m series A
The healthcare engagement technology provider has received $12m in a round co-led by the Blue Cross Blue Shield-backed Blue Venture Fund.
Feb 12, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
